Jan Van Droogenbroeck

1.6k total citations · 1 hit paper
31 papers, 789 citations indexed

About

Jan Van Droogenbroeck is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Jan Van Droogenbroeck has authored 31 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Jan Van Droogenbroeck's work include Multiple Myeloma Research and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Jan Van Droogenbroeck is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Jan Van Droogenbroeck collaborates with scholars based in Belgium, United States and France. Jan Van Droogenbroeck's co-authors include Dong‐Wook Kim, Jörge E. Cortes, Hagop M. Kantarjian, Jorge Milone, María Soledad Undurraga, Carolina Pavlovsky, Chao Zhu, Michele Baccarani, Neil P. Shah and M B Agarwal and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Jan Van Droogenbroeck

28 papers receiving 771 citations

Hit Papers

Dasatinib or imatinib in newly diagnosed chronic-phase ch... 2011 2026 2016 2021 2011 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
    2011 441 citations Hagop M. Kantarjian, Neil P. Shah et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Van Droogenbroeck Belgium 10 507 401 234 173 158 31 789
P.E. Dorlhiac‐Llacer Brazil 12 757 1.5× 523 1.3× 303 1.3× 141 0.8× 96 0.6× 20 986
Mario Annunziata Italy 17 592 1.2× 255 0.6× 108 0.5× 141 0.8× 202 1.3× 51 776
Pierluigi Rossi Ferrini Italy 18 655 1.3× 458 1.1× 205 0.9× 168 1.0× 341 2.2× 56 1.1k
Muhlis Cem Ar Türkiye 14 340 0.7× 210 0.5× 76 0.3× 128 0.7× 120 0.8× 113 655
Elvira Deolinda Rodrigues Pereira Velloso Brazil 13 423 0.8× 209 0.5× 129 0.6× 77 0.4× 184 1.2× 81 654
Dong Soon Lee South Korea 18 575 1.1× 252 0.6× 74 0.3× 203 1.2× 329 2.1× 75 882
Paola Masolini Italy 17 389 0.8× 187 0.5× 165 0.7× 294 1.7× 252 1.6× 24 849
Eros Di Bona Italy 17 835 1.6× 184 0.5× 174 0.7× 169 1.0× 394 2.5× 46 1.1k
C. G. Geary United Kingdom 20 856 1.7× 439 1.1× 115 0.5× 149 0.9× 185 1.2× 62 1.2k
G Broccia Italy 16 695 1.4× 243 0.6× 54 0.2× 212 1.2× 172 1.1× 39 931

Countries citing papers authored by Jan Van Droogenbroeck

Since Specialization
Citations

This map shows the geographic impact of Jan Van Droogenbroeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Van Droogenbroeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Van Droogenbroeck more than expected).

Fields of papers citing papers by Jan Van Droogenbroeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Van Droogenbroeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Van Droogenbroeck. The network helps show where Jan Van Droogenbroeck may publish in the future.

Co-authorship network of co-authors of Jan Van Droogenbroeck

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Van Droogenbroeck. A scholar is included among the top collaborators of Jan Van Droogenbroeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Van Droogenbroeck. Jan Van Droogenbroeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Droogenbroeck, Jan Van, et al.. (2023). Perifoveal exudative vascular anomalous complex (PEVAC) resembling lesion in a patient with multiple myeloma. American Journal of Ophthalmology Case Reports. 34. 101891–101891. 3 indexed citations
2.
Praet, Jens Van, Stefanie De Buyser, Sylvia Snauwaert, et al.. (2022). Infectious diarrhea after allogeneic hematopoietic cell transplantation assessed by a multiplex polymerase chain reaction assay. International Journal of Infectious Diseases. 127. 17–22. 7 indexed citations
3.
Hoovels, Lieve Van, Martine Vercammen, Dries Deeren, et al.. (2022). Serum free light chain analysis: persisting limitations with new kids on the block. Clinical Chemistry and Laboratory Medicine (CCLM). 60(9). 1440–1448.
4.
5.
Olivier, P.A.S., Noriko Salamon, Jan Casselman, Jan Van Droogenbroeck, & Ludo Vanopdenbosch. (2019). Cerebellar progressive multifocal leukoencephalopathy in a patient with a history of Crohn’s disease and acute myeloid leukemia. Acta Neurologica Belgica. 120(3). 759–760.
6.
Weisel, Katja, Chantal Doyen, Meletios Α. Dimopoulos, et al.. (2016). A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation. Leukemia & lymphoma. 58(1). 153–161. 32 indexed citations
7.
Hansson, Markus, Peter Gimsing, Ashraf Badros, et al.. (2015). A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma. Clinical Cancer Research. 21(12). 2730–2736. 42 indexed citations
8.
Devos, Timothy, Pierre Zachée, Dominique Bron, et al.. (2014). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica. 70(2). 105–111. 6 indexed citations
9.
Zeidler, Cornelia, Ulrike Grote, Alexander Nickel, et al.. (2014). Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry. Haematologica. 99(8). 1395–1402. 27 indexed citations
10.
Caers, Jo, Marie‐Christiane Vekemans, Karolien Beel, et al.. (2013). Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians. Annals of Medicine. 45(5-6). 413–422. 9 indexed citations
11.
12.
Kantarjian, Hagop M., Neil P. Shah, Jörge E. Cortes, et al.. (2011). Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION). Blood. 119(5). 1123–1129. 441 indexed citations breakdown →
13.
Vriese, An S. De, et al.. (2008). Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans. Journal of Internal Medicine. 263(4). 395–403. 27 indexed citations
14.
Hughes, Derralynn, Maria Domenica Cappellini, Marc Berger, et al.. (2007). Recommendations for the management of the haematological and onco‐haematological aspects of Gaucher disease1. British Journal of Haematology. 138(6). 676–686. 66 indexed citations
15.
Droogenbroeck, Jan Van, et al.. (2001). Intravascular large B-cell lymphoma or intravascular lymphomatosis: report of a case diagnosed by testicle biopsy. Annals of Hematology. 80(5). 316–318. 17 indexed citations
16.
Bottieau, Emmanuel, Robert Colebunders, Wilfried Schroyens, et al.. (2000). Multicentric Castleman’s Disease in 2 Patients with HIV Infection, Unresponsive to Antiviral Therapy. Acta Clinica Belgica. 55(2). 97–101. 12 indexed citations
17.
Droogenbroeck, Jan Van, et al.. (1998). Successful treatment of cytomegalovirus encephalitis in a patient with Hodgkin's disease in remission. Annals of Hematology. 76(3-4). 179–181. 4 indexed citations
18.
19.
Droogenbroeck, Jan Van & A. Vermeulen. (1989). PLASMA ANDROSTANEDIOL GLUCURONIDE LEVELS DURING PREGNANCY. Clinical Endocrinology. 31(4). 425–429. 2 indexed citations
20.
Droogenbroeck, Jan Van, et al.. (1985). [Surgical decompression of neuritis of Hansen's disease].. PubMed. 3(1). 37–66. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.E. Dorlhiac‐Llacer Breakdown of academic impact, for papers by Mario Annunziata Breakdown of academic impact, for papers by Pierluigi Rossi Ferrini Breakdown of academic impact, for papers by Muhlis Cem Ar Breakdown of academic impact, for papers by Elvira Deolinda Rodrigues Pereira Velloso Breakdown of academic impact, for papers by Dong Soon Lee Breakdown of academic impact, for papers by Paola Masolini Breakdown of academic impact, for papers by Eros Di Bona Breakdown of academic impact, for papers by C. G. Geary Breakdown of academic impact, for papers by G Broccia
Rankless by CCL
2026